2008
DOI: 10.1016/j.bbamem.2008.04.010
|View full text |Cite
|
Sign up to set email alerts
|

A novel catalytic mechanism for ATP hydrolysis employed by the N-terminal nucleotide-binding domain of Cdr1p, a multidrug ABC transporter of Candida albicans

Abstract: Although essentially conserved, the N-terminal nucleotide-binding domain (NBD) of Cdr1p and other fungal transporters has some unique substitutions of amino acids which appear to have functional significance for the drug transporters. We have previously shown that the typical Cys193 in Walker A as well as Trp326 and Asp327 in the Walker B of N-terminal NBD (NBD-512) of Cdr1p has acquired unique roles in ATP binding and hydrolysis. In the present study, we show that due to spatial proximity, fluorescence resona… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
1
1

Relationship

3
5

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 38 publications
0
5
0
Order By: Relevance
“…Analogous results were found with P-gp (17). In reporting on a study that used FRET (Forster resonance energy transfer) Rai et al suggested a role for the equivalent Cdr1 residue (Glu-237) in coordinating the Mg ion during ATP hydrolysis, but this study was carried out with a single, purified NBD and did not look directly at ATPase activity or determine a drug phenotype (18). …”
Section: Resultsmentioning
confidence: 99%
“…Analogous results were found with P-gp (17). In reporting on a study that used FRET (Forster resonance energy transfer) Rai et al suggested a role for the equivalent Cdr1 residue (Glu-237) in coordinating the Mg ion during ATP hydrolysis, but this study was carried out with a single, purified NBD and did not look directly at ATPase activity or determine a drug phenotype (18). …”
Section: Resultsmentioning
confidence: 99%
“…Conformational changes induced by ATP binding and/or hydrolysis are transmitted from the NBDs to the TMDs, which can result in drug translocation, drug efflux, or resetting of the reaction cycle (Gupta et al, 2011). In addition to powerhouse of the protein, several residues in NBDs have also been found to alter drug specificity toward many drugs as shown in Figure 3 (Jha et al, 2003, 2004; Shukla et al, 2003; Rai et al, 2005, 2006, 2008; Kumar et al, 2010; Prasad et al, 2012). The typical feature of all yeast ABC transporters of PDR family is that they exhibit high basal ATPase activity and that the most commonly observed feature of drug stimulated ATPase activity component is completely absent from yeast proteins.…”
Section: Abc Proteins In Candidamentioning
confidence: 99%
“…The experiments that followed to investigate the functional relevance of sequence degeneracy in isolated domains revealed that atypical C193 of Walker A and W326 of Walker B of N-NBD are in close proximity in the ATP binding pocket, where the former residue participates in hydrolysis while the latter impacts the binding of the nucleotide (35,36). Interestingly, well-conserved D327, which is otherwise the catalytic carboxylate in other ABC transporters, appears to have a new role and behaves as a catalytic base involved in ATP hydrolysis in this transporter (37).…”
Section: The Conserved Nbds Power Drug Effluxmentioning
confidence: 99%